Below are the most recent publications written about "Urination Disorders" by people in Profiles.
-
Kesty K, Edenfield A, Castro D, Medina L, Naser M, Manríquez V, Swift S. Subjective versus objective determination of bladder emptying following urogynecological surgery: "do you feel that you completely emptied your bladder?" Int Urogynecol J. 2020 09; 31(9):1899-1905.
-
Shore ND, Boorjian SA, Canter DJ, Ogan K, Karsh LI, Downs TM, Gomella LG, Kamat AM, Lotan Y, Svatek RS, Bivalacqua TJ, Grubb RL, Krupski TL, Lerner SP, Woods ME, Inman BA, Milowsky MI, Boyd A, Treasure FP, Gregory G, Sawutz DG, Yla-Herttuala S, Parker NR, Dinney CPN. Intravesical rAd-IFNa/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. J Clin Oncol. 2017 Oct 20; 35(30):3410-3416.
-
Shunmugavel A, Khan M, Hughes FM, Purves JT, Singh A, Singh I. S-Nitrosoglutathione protects the spinal bladder: novel therapeutic approach to post-spinal cord injury bladder remodeling. Neurourol Urodyn. 2015 Aug; 34(6):519-26.
-
Victorson DE, Brucker PS, Bode RK, Eton DT, Talcott JA, Clark JA, Knight SJ, Litwin MS, Moinpour CM, Reeve BB, Aaronson NK, Bennett CL, Herr HW, McGuire M, Shevrin D, McVary K, Cella D. Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance. Urol Oncol. 2014 Jan; 32(1):26.e25-31.
-
Kawasaki A, Edenfield AL, Visco AG, Wu JM, Westreich D, Siddiqui NY. Comparing the risk of urethrolysis for the treatment of voiding dysfunction between two retropubic mesh slings: a case-control study. Int Urogynecol J. 2013 Apr; 24(4):589-94.
-
Dighe M, Francis IR, Casalino DD, Arellano RS, Baumgarten DA, Curry NS, Fulgham P, Israel GM, Leyendecker JR, Papanicolaou N, Prasad S, Ramchandani P, Remer EM, Sheth S. ACR appropriateness criteria on obstructive voiding symptoms secondary to prostate disease. J Am Coll Radiol. 2010 Apr; 7(4):255-9.
-
Wood SK, Baez MA, Bhatnagar S, Valentino RJ. Social stress-induced bladder dysfunction: potential role of corticotropin-releasing factor. Am J Physiol Regul Integr Comp Physiol. 2009 May; 296(5):R1671-8.
-
Kaplan SA, Roehrborn CG, Dmochowski R, Rovner ES, Wang JT, Guan Z. Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia. Urology. 2006 Aug; 68(2):328-32.
-
Rackley R, Weiss JP, Rovner ES, Wang JT, Guan Z. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006 Apr; 67(4):731-6; discussion 736.
-
Smith A, Rovner E. Long-term chronic complications from Stamey endoscopic bladder neck suspension: a case series. Int Urogynecol J Pelvic Floor Dysfunct. 2006 May; 17(3):290-4.